VectivBio Alternatives & Competitors

12 companies similar to VectivBio — Biotech company develops treatments for severe rare diseases, aims to become glo...

Doc990 l Digital Health Private Limited

37 Series A $49.48M

Sri Lanka

Health Care Mobile

CERo Therapeutics, Inc.

Tumor Cell Clearance Reimagined.

16 Series A $41.40M

South San Francisco, Unit...

Biotechnology Health and Wellness

SyMap Medical

Crafting advanced, catheter-based systems for renal denervation therapy aimed at treating...

1 Series E $170.00M

Biotechnology Health Care +1

Medasense Biometrics Ltd.

NOL-Nociception Level Index® - AI-driven technology transforming personalized PAIN monitor...

26 Series C $31.50M

Israel

AI Health Care +2

Track all VectivBio competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

NBE-Therapeutics AG

Next generation antibody drug conjugates

48 Series C

Basel, Switzerland

Biotechnology Health Care +1

BeiGene

BeiGene (Beijing) Co., Ltd. is a life sciences biotechnology company

2164 IPO $6.69B

Cambridge, United States

Xeno Biosciences

Gastric Bypass in a Pill

3 Series A $8.75M

Cambridge, United States

Biotechnology Health Care +1

Berlin Institute of Health in der Charité

Aus Forschung wird Gesundheit

561

Berlin, Germany

Biotechnology Health Care +1

Asylia Therapeutics

Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious...

1 Series A $14.50M

Biotechnology Health Care +1

Signet Therapeutics Inc.

Address Unmet Medical Needs Through Innovation.

5 Series A $150.00M

Boston, United States

Endogenex

Treating the gut may redefine what's possible in diabetes care.

27 Series C $113.00M

Plymouth, United States

Health Care Health and Wellness +1

HepaRegeniX GmbH

Unlocking liver regeneration - delivering recovery

15 Unknown $57.69M

Tubingen, Germany

Biotechnology Health Care +2

About VectivBio

Biotech company develops treatments for severe rare diseases, aims to become global leader with patient-centric approach.

Services

GI Treatment Advancement, Pharmaceutical Development, Patient Outcome Improvement, Research & Development

Target Customers

GI Patients, Healthcare Providers, Hospitals, Medical Researchers

Taxonomy

Rare Diseases, Clinical-Stage Biotech, Patient-Centric Approach, Orphan Conditions, Drug Development, Therapy Commercialization, Innovative Medicines, Spinout Company, Translational Research, Life-Changing Therapies, Severe Illnesses, Targeted Therapies, Medical Needs

Business Model

B2B, B2D

Revenue Model

Product Sales, Licensing

Frequently Asked Questions

Top alternatives to VectivBio include Doc990 l Digital Health Private Limited, CERo Therapeutics, Inc., SyMap Medical, Medasense Biometrics Ltd., NBE-Therapeutics AG. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to VectivBio based on industry overlap, target customers, and business model.

Biotech company develops treatments for severe rare diseases, aims to become global leader with patient-centric approach.

Don't just read about them. Follow them.

BounceWatch watches VectivBio and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

VectivBio Profile Doc990 l Digital Health Private Limited Alternatives CERo Therapeutics, Inc. Alternatives SyMap Medical Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at VectivBio on 27 Jan 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 28 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.